China (Mainland)
Assessedsupplier
Dapoxetine hydrochloride 129938-20-1 CAS NO.129938-20-1
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Product Details
Keywords
- 129938-20-1
- Dapoxetine hydrochloride
- (1s)-n,n-dimethyl-3-naphthalen-1-yloxy-1-phenyl-propan-1-amine hydrochloride
Quick Details
- ProName: Dapoxetine hydrochloride 129938-20-1
- CasNo: 129938-20-1
- Molecular Formula: C9H7ClN2O5
- Appearance: white powder
- Application: Dapoxetine hydrochloride 129938-20-1
- DeliveryTime: prompt
- PackAge: 25kg plastic drum
- Port: shanghai
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99% min
- Storage: room temperature
- Transportation: as per msds
- LimitNum: 1 Kilogram
- Heavy metal: N/A
- Grade: Industrial Grade,Food Grade,Pharma Gra...
- Transporttation: N/A
Superiority
| Dapoxetine hydrochloride Basic information |
| Product Name: | Dapoxetine hydrochloride |
| Synonyms: | (1s)-n,n-dimethyl-3-naphthalen-1-yloxy-1-phenyl-propan-1-amine hydrochloride;DAPOXETINE HCL;DAPOXETINE HYDROCHLORIDE CHEMISTRY PURE 98.5% HPLC ;Rimonabant 75000;(aS)-N,N-Dimethyl-a-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine;LY-21044;((S)-(+)-N,N-Dimethyl-1-phenyl-3-(1-naphthalenyloxy)propanamine hydrochloride);(S)-(+)--N,N-Dimethyl-1-phenyl-3-(1-naphthalenyloxy)propanamine |
| CAS: | 129938-20-1 |
| MF: | C9H7ClN2O5 |
| MW: | 258.62 |
| EINECS: | |
| Product Categories: | Intermediates & Fine Chemicals;Pharmaceuticals;Amines;Aromatics;Inhibitors;Dapoxetine Hydrochloride |
| Mol File: | 129938-20-1.mol |
|
|
|
Details
| Dapoxetine hydrochloride Chemical Properties |
| mp | 175-1790C |
| storage temp. | -20°C Freezer |
| CAS DataBase Reference | 129938-20-1(CAS DataBase Reference) |
| Safety Information |
| Hazard Codes | Xn,N |
| Risk Statements | 22-36-50/53 |
| Safety Statements | 36-60-61 |
| Dapoxetine hydrochloride Usage And Synthesis |
| Chemical Properties | Off-white Cryst |
| Usage | Dapoxetine hydrochloride is a short-acting novel selective serotonin reuptake inhibitor marketed for the treatment of premature ejaculation in men. Premature ejaculation (PE) is the most common male sexual disorder, estimated to affect up to 30% of men. D |
| Usage | A selective serotonin reuptake inhibitor |
| Usage | Selective serotonin reuptake inhibitor (SSRI) |